BioSpace News Archive

Drug Development

UCB, Inc. Release: New Data From REALISTIC Study Showed Cimzia(R) (certolizumab pegol) Provided Rapid and Sustained Efficacy, Over 28 Weeks, in a Broad Population of Patients With Moderate to Severe Rheumatoid Arthritis (RA) Including Those Who Discontinu

November 7, 2011
·
16 min read
Drug Development

UCB, Inc. Release: New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia(R) (certolizumab pegol) at Week 12 was Predictive of Week 52 Response

November 7, 2011
·
16 min read
Drug Development

Abbott Laboratories Presents HUMIRA(R) (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis

November 7, 2011
·
6 min read
Business

Dehaier Medical Systems Ltd. to Report Third Quarter 2011 Financial Results on November 14

November 7, 2011
·
2 min read
Drug Development

Evolva SA Receives Clearance to Move EV-077 into Phase 2

November 7, 2011
·
2 min read
China Nuokang Bio-Pharmaceutical Inc. to Present at Cowen’s China Opportunity Conference

November 7, 2011
·
1 min read
Bio NC

Curaxis Pharmaceutical Corp. Management to Meet With Shareholders

November 7, 2011
·
1 min read
BioMidwest

Medicis to Present at Credit Suisse 2011 Healthcare Conference

November 7, 2011
·
1 min read
Business

Sagent Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results

November 7, 2011
·
1 min read
FDA Revises IntelGenx Corp.’ CPI-300 PDUFA Date to November 10th

November 7, 2011
·
1 min read